These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31383393)

  • 1. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
    Rudin D; Spoendlin J; Cismaru AL; Liakoni E; Bonadies N; Amstutz U; Meier CR; Krähenbühl S; Haschke M
    Eur J Intern Med; 2019 Oct; 68():36-43. PubMed ID: 31383393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports.
    Blaser LS; Tramonti A; Egger P; Haschke M; Krähenbühl S; Rätz Bravo AE
    Eur J Clin Pharmacol; 2015 Feb; 71(2):209-17. PubMed ID: 25401171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
    Lerman TT; Sagi M; Shafir Y; Sheena L; Cohen E; Goldberg E; Krause I
    Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
    Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
    Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
    Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations.
    Cismaru AL; Rudin D; Ibañez L; Liakoni E; Bonadies N; Kreutz R; Carvajal A; Lucena MI; Martin J; Sancho Ponce E; Molokhia M; Eriksson N; EuDAC Collaborators ; Krähenbühl S; Largiadèr CR; Haschke M; Hallberg P; Wadelius M; Amstutz U
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33138277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metamizole use by Latino immigrants: a common and potentially harmful home remedy.
    Bonkowsky JL; Frazer JK; Buchi KF; Byington CL
    Pediatrics; 2002 Jun; 109(6):e98. PubMed ID: 12042592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and region.
    Hoffmann F; Meinecke P; Freitag MH; Glaeske G; Schulze J; Schmiemann G
    J Clin Pharm Ther; 2015 Jun; 40(3):285-8. PubMed ID: 25776531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Agranulocytosis and metamizole].
    Hoerder U; König HJ; Hartwich G
    Dtsch Med Wochenschr; 1982 Dec; 107(50):1923-6. PubMed ID: 7140576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis.
    García-Martín E; Esguevillas G; Blanca-López N; García-Menaya J; Blanca M; Amo G; Canto G; Martínez C; Cordobés C; Agúndez JA
    Pharmacogenet Genomics; 2015 Sep; 25(9):462-4. PubMed ID: 26111152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.